Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Estetrol (E4) may help treat female pattern hair loss by prolonging hair growth.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

AGEs and their receptors play a significant role in hair loss by causing inflammation and oxidative stress.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Estetrol may help prevent hair loss and promote hair growth in women.

Damaged hair follicle stem cells may leave the skin to help maintain youthfulness.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Higher fluence in hair removal damages hair follicles more, while lower fluence mimics natural hair regression, with long-term IPL treatments effectively reducing hair.

A 14-year-old boy was diagnosed with a rare hair condition that may lead to hair thinning and has no known effective treatments.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Changing hair follicle identity could potentially reverse balding.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

A new method using fat tissue cells may help treat hair loss.

New methods can diagnose hair loss by examining the scalp and can treat it with a mix of oral and topical medications, along with cosmetic procedures like hair transplants.

Artemis dysfunction might cause hair loss through telomere shortening.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed for hair growth.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed for hair growth.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed to grow hair.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.